217 related articles for article (PubMed ID: 25782201)
1. [Erythropoiesis stimulating agents in clinical practice].
Niemczyk L; Dębowska M
Wiad Lek; 2014; 67(3):413-5. PubMed ID: 25782201
[TBL] [Abstract][Full Text] [Related]
2. Darbepoetin for the anaemia of chronic kidney disease.
Palmer SC; Saglimbene V; Craig JC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009297. PubMed ID: 24683046
[TBL] [Abstract][Full Text] [Related]
3. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
Wilhelm-Leen ER; Winkelmayer WC
Am J Kidney Dis; 2015 Jul; 66(1):69-74. PubMed ID: 25636816
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of renal anemia with darbepoetin alfa administered once every other week in predialysis patients with chronic kidney disease and previously treated with epoetin alfa].
Molina M; García Hernández MA; Navarro MJ; Pérez Silva F; Cacho M; De Gracia MC
Nefrologia; 2004; 24(1):54-9. PubMed ID: 15083958
[TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
Chen HH; Tarng DC; Lee KF; Wu CY; Chen YC
J Nephrol; 2008; 21(4):543-9. PubMed ID: 18651544
[TBL] [Abstract][Full Text] [Related]
6. [Current issues in erythropoietin therapy of renal anemia].
Zakar G
Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
[TBL] [Abstract][Full Text] [Related]
7. Effects of Epoetin alfa on hemostasis in chronic renal failure.
Tang WW; Stead RA; Goodkin DA
Am J Nephrol; 1998; 18(4):263-73. PubMed ID: 9653828
[TBL] [Abstract][Full Text] [Related]
8. Anemia in chronic kidney disease: causes, diagnosis, treatment.
Nurko S
Cleve Clin J Med; 2006 Mar; 73(3):289-97. PubMed ID: 16548452
[TBL] [Abstract][Full Text] [Related]
9. Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.
Piotr B; Mariusz S; Jacek R
Curr Pharm Biotechnol; 2017; 18(4):303-308. PubMed ID: 28137221
[TBL] [Abstract][Full Text] [Related]
10. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
Agarwal AK
J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
[TBL] [Abstract][Full Text] [Related]
11. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
12. Novel erythropoiesis-stimulating agents: a new era in anemia management.
Macdougall IC
Clin J Am Soc Nephrol; 2008 Jan; 3(1):200-7. PubMed ID: 18077782
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of response to various erythropoiesis--stimulating proteins using anemia management software.
Waterschoot M
J Ren Care; 2007; 33(2):78-82. PubMed ID: 17702511
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist's role in managing anemia in patients with chronic kidney disease: potential clinical and economic benefits.
Gilmartin C
Am J Health Syst Pharm; 2007 Jul; 64(13 Suppl 8):S15-22; quiz S23-5. PubMed ID: 17591991
[TBL] [Abstract][Full Text] [Related]
15. Probabilistic cost-minimisation analysis of darbepoetin alpha versus epoetin alpha in treating anaemia secondary to chronic renal failure. Assessment in Spanish clinical practice.
Sanz-Granda A
Farm Hosp; 2009; 33(4):208-16. PubMed ID: 19712609
[TBL] [Abstract][Full Text] [Related]
16. Anemia of renal disease: what it is, what to do and what's new.
Chalhoub S; Langston C; Eatroff A
J Feline Med Surg; 2011 Sep; 13(9):629-40. PubMed ID: 21872790
[TBL] [Abstract][Full Text] [Related]
17. Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.
Tonelli M; Owen WF; Jindal K; Winkelmayer WC; Manns B
Kidney Int; 2004 Oct; 66(4):1712; author reply 1712-3. PubMed ID: 15458473
[No Abstract] [Full Text] [Related]
18. Recombinant erythropoietin in clinical practice.
Ng T; Marx G; Littlewood T; Macdougall I
Postgrad Med J; 2003 Jul; 79(933):367-76. PubMed ID: 12897214
[TBL] [Abstract][Full Text] [Related]
19. Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease.
Foley RN
Rev Cardiovasc Med; 2005; 6 Suppl 3():S27-34. PubMed ID: 16340936
[TBL] [Abstract][Full Text] [Related]
20. Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease.
Warady BA; Arar MY; Lerner G; Nakanishi AM; Stehman-Breen C
Pediatr Nephrol; 2006 Aug; 21(8):1144-52. PubMed ID: 16724235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
